Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Consolidation Chemotherapy × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1

Interventions

Specimen Handling 183 Magnetic Resonance Spectroscopy 134 Biopsy 106 pembrolizumab 100 Carboplatin 76 Nivolumab 73 Cisplatin 71 Gemcitabine 56 Cyclophosphamide 55 Radiotherapy 50 Paclitaxel 50 Rituximab 40 venetoclax 39 Bevacizumab 39 durvalumab 38 atezolizumab 34 Prednisone 34 Dexamethasone 34 X-Rays 32 Radiation 32 Taxes 31 Oxaliplatin 31 Cytarabine 30 Ipilimumab 29 Immunoglobulin G 28 Docetaxel 28 Disulfides 28 Radiosurgery 27 Fluorouracil 27 Doxorubicin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06162650 2026-04-08

Total Neoadjuvant Therapy in Rectal Cancer

National Cheng-Kung University Hospital

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡